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Abstract
There is increasing evidence that strain variation in Mycobacterium tuberculosis complex (MTBC) might influence the
outcome of tuberculosis infection and disease. To assess genotype-phenotype associations, phylogenetically robust
molecular markers and appropriate genotyping tools are required. Most current genotyping methods for MTBC are based
on mobile or repetitive DNA elements. Because these elements are prone to convergent evolution, the corresponding
genotyping techniques are suboptimal for phylogenetic studies and strain classification. By contrast, single nucleotide
polymorphisms (SNP) are ideal markers for classifying MTBC into phylogenetic lineages, as they exhibit very low degrees of
homoplasy. In this study, we developed two complementary SNP-based genotyping methods to classify strains into the six
main human-associated lineages of MTBC, the ‘‘Beijing’’ sublineage, and the clade comprising Mycobacterium bovis and
Mycobacterium caprae. Phylogenetically informative SNPs were obtained from 22 MTBC whole-genome sequences. The first
assay, referred to as MOL-PCR, is a ligation-dependent PCR with signal detection by fluorescent microspheres and a Luminex
flow cytometer, which simultaneously interrogates eight SNPs. The second assay is based on six individual TaqMan real-time
PCR assays for singleplex SNP-typing. We compared MOL-PCR and TaqMan results in two panels of clinical MTBC isolates.
Both methods agreed fully when assigning 36 well-characterized strains into the main phylogenetic lineages. The sensitivity
in allele-calling was 98.6% and 98.8% for MOL-PCR and TaqMan, respectively. Typing of an additional panel of 78 unknown
clinical isolates revealed 99.2% and 100% sensitivity in allele-calling, respectively, and 100% agreement in lineage
assignment between both methods. While MOL-PCR and TaqMan are both highly sensitive and specific, MOL-PCR is ideal for
classification of isolates with no previous information, whereas TaqMan is faster for confirmation. Furthermore, both
methods are rapid, flexible and comparably inexpensive.
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Introduction
Genotyping of human-associated Mycobacterium tuberculosis com-
plex (MTBC) plays an increasing role for understanding the
epidemiology and biology of tuberculosis (TB) [1,2]. On the one
hand, genotyping techniques are key for standard molecular
epidemiological investigations of TB such as defining chains of
ongoing transmission and differentiating patient relapse from
exogenous re-infection [1]. On the other hand, strain genotyping
in MTBC is important for defining the evolutionary background
of clinical isolates. There is mounting evidence that the strain
genetic background might influence the outcome of TB infection
and disease. Experimental studies have shown that clinical strains
differ in immunogenicity and virulence, but whether this variation
translates into comparable clinical phenotypes is unclear [2–9]. To
study the effect of strain variation and detect relevant genotype-
phenotype associations, suitable phylogenetic markers and appro-
priate genotyping methods are required [10].
Several methods for genotyping of MTBC have been developed
over the past years [11]. Two of the most popular methods,
spoligotyping [12] and MIRU-VNTR [13], rely on repetitive
DNA elements, and are currently considered the gold standard for
TB transmission studies [1,13]. However, due to their propensity
for convergent evolution and resulting homoplasies [10], inferring
robust phylogenies using these methods can be problematic.
Moreover, because of these homoplasies, classification of MTBC
strains into robust phylogenetic lineages is not always possible and
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misclassification can occur [14,15]. In addition to mobile genetic
elements (e.g. IS6110 [16]), repetitive DNA (DR region [17],
MIRU-VNTR [18]), and large sequence polymorphisms
[19,20], single nucleotide polymorphisms (SNPs) have become
available as phylogenetic markers for MTBC. SNPs are ideal
markers for genotyping of MTBC, as they represent unique
events and show virtually no homoplasy [10]. Several studies
have reported the use of SNPs for phylogenetic classification of
MTBC [21–29]. However, no consensus has yet been reached as
to what set of SNPs should be used for standard phylotyping of
MTBC. Importantly, not all phylogenetically informative SNPs
will be equally amendable to all possible SNP-typing platforms
[30,31]. In MTBC, some of the methods that have been
proposed are allele-specific PCR [32], real-time PCR [33],
Sanger sequencing [34], SNaPshot minisequencing [28], iPlex
Gold (SEQUENOM Inc.) [29] and MLPA [25]. All of these
methods differ in their technical requirements. Hence, depend-
ing on the particular technique used, different, but phylogenet-
ically equivalent SNP sets will be required. In addition, these
typing methods vary largely in their throughput, cost, and
flexibility. With respect to the latter, we identified a lack of
methods, which are at the same time flexible and rapid (,1 day/
96 samples), and amendable to a variable number of strains and
a limited number of SNPs (5–50).
Recently, whole genome sequences of a global collection of 21
MTBC strains representing the six main lineages of human-
associated MTBC became available [35]. The 9,037 SNPs
identified in these genomes represent an ideal starting point for
extracting diagnostic or ‘‘canonical’’ SNPs, which are lineage-
specific, to design phylogenetically robust genotyping assays [36].
In this study, we present two new and complementary SNP-typing
methods for MTBC. These methods are based on two phyloge-
netically equivalent sets of SNP markers that are specific for the 6
main human-associated lineages of MTBC. Additionally, we
present SNPs specific for the clade comprising Mycobacterium bovis
and Mycobacterium caprae [26], and for the ‘‘Beijing’’-sublineage of
Lineage 2 (East-Asian) (Figure 1). ‘‘Beijing’’ strains are of special
epidemiological interest because of their repeated association with
drug resistance and hypervirulence in infection models [37,38].
The M. bovis/M. caprae specific SNP does not capture the other
animal-associated strains, i.e. M. pinnipedii, M. microti, M. orygis, M.
mungi and the Dassie bacillus.
The first SNP-typing method is MOL-PCR (multiplexed
oligonucleotide ligation PCR) [39], which uses allele-specific
ligation for allele discrimination, singleplex PCR for signal
amplification and fluorescent microspheres (beads) for the signal
detection on a flow cytometer (Figure 2, see Methods). A Luminex
device is needed; i.e. a flow cytometric platform for various nucleic
acid and immunological assays [40–42], which allows for
simultaneous interrogation of 50 biallelic SNPs. MOL-PCR is
flexible for both the number of SNPs as well as for the number of
strains tested (individual tubes to 96-well plates). We developed an
8-plex SNP-typing assay for the identification of the main
phylogenetic lineages of MTBC. As a second method, we present
SNP-typing with TaqMan real-time PCR. As a commercially
available system, TaqMan has proved to be sensitive and specific
in numerous studies for various applications and species [43–46],
and is therefore considered the standard for SNP-typing in our
laboratory [14,20]. Reactions are performed in a 96-well format in
less than 2 hours. In contrast to MOL-PCR, only one SNP is
assessed per reaction.
Methods
Ethics statement
All MTBC strains used in this study were from published
reference collections [14,20,26,47–49] or from an ongoing
molecular epidemiology study on tuberculosis in Nepal. This
study was ethically approved by the Nepal Health Research
Council (NHRC), Kathmandu, Nepal, and the Ethics Committee
of Basel, Switzerland (EKBB). Written informed consent was
obtained from all Nepalese patients.
Strain panels
Two different strain panels were used in this study. A ‘‘training
panel’’ of 46 MTBC strains was first chosen for establishing the
MOL-PCR and TaqMan assays. These strains had been
characterized previously by spoligotyping and were available as
crude lysates and purified DNA. This training panel contained
clinical strains from published reference collections [14,20,26,47–
49] and some clinical isolates from Nepal (manuscript in
preparation). The training panel was composed of five to seven
isolates of the 6 main phylogenetic lineage of MTBC, and
additionally, Mycobacterium bovis, Mycobacterium caprae, Mycobacterium
pinnipedii and Mycobacterium microti as controls for the M. bovis/M.
caprae-specific SNP in the MOL-PCR assay. For each of these
strains, SNP-typing was done by MOL-PCR and TaqMan for
both crude lysates and purified DNA. Allele calls, i.e. lineage
assignments, were obtained for all data points, and results between
the two methods compared. As it was not possible to use the same
SNPs for both MOL-PCR and TaqMan (due to probe design
restrictions), we compared the lineage assignment rather than the
locus-specific alleles.
A ‘‘test panel’’ was then chosen for the validation of MOL-PCR
and TaqMan under ‘‘blind’’ conditions. This test panel consisted
of 78 clinical MTBC isolates recently obtained from a molecular
epidemiology study in Nepal. No previous genotyping had been
done for these samples. The samples were cultured on Lo¨wenstein-
Jenssen (LJ) medium, frozen in tryptic soy agar and glycerol, and
heat-inactivated for 1 h at 90uC. Purified DNA was available for
fifteen of these strains.
Culturing and DNA extraction
MTBC strains were grown in standard Middlebrook 7H9
medium supplemented with ADC (Becton Dickinson, Allschwil,
Switzerland), Tween80 (Sigma-Aldrich) and glycerol (Sigma-
Aldrich). Liquid medium and agar plates for culturing Mycobac-
terium africanum (i.e. MTBC Lineage 5 and 6) were supplemented
with 40 mM sodium pyruvate (Sigma-Aldrich). All bacterial
cultures were incubated at 37uC. After two weeks, 500 mL culture
were heat-inactivated (1 hour at 90uC) and centrifuged. The
supernatant was used as input for TaqMan and MOL-PCR.
Alternatively, 100 mL of a frozen stock culture was thawed and
heat-inactivated (100 mL culture added to 100 mL TE buffer,
1 hour at 90uC). From all cultures, purified genomic DNA was
extracted with the CTAB method [50]. DNA concentration was
determined with a Nanodrop ND-1000 device (Thermo Scientific
NanoDrop Products, Wilmington, USA).
Whole genome sequencing and SNP identification
Informative SNPs were obtained from whole genome sequenc-
ing as described before [35,51]. In brief, short reads from
Illumina-sequencing of 22 MTBC strains were mapped to the
reference genome of H37Rv and strain-specific nucleotide
differences were extracted as SNPs. A neighbor-joining phyloge-
netic tree was constructed with MEGA [52], and SNPs mapped to
SNP-Typing for M. tuberculosis Complex
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the tree using Mesquite [53]. Clade-specific SNPs were compiled
in OpenOffice spreadsheets (openoffice.org). Position in reference
to H37Rv, codon change, essentiality [54,55], and annotated
function of the gene [56] were collected for each SNP. This list was
used as a starting point for oligonucleotide design. In the course of
the study, 151 additional genome sequences became available
(manuscript in preparation). With the total of 172 genome
sequences representing the global MTBC diversity, we confirmed
that the SNPs chosen were specific for all members of a lineage. In
reference to the first MTBC genome sequenced and annotated
[56] (Genbank AL123456.2), every SNP was named with the
prefix ‘‘Rv’’, followed by 7 digits that represent the position of this
SNP in the genome of H37Rv, and the nucleotide change (i.e.
‘‘Rv2154724AC’’ for the Lineage 4-specific SNP in katG, codon
463).
Assay description Luminex MOL-PCR
The assay described here is conceptually related to Multiplex
Ligation-dependent Probe Amplification (MLPA) that was also
described for SNP-typing of M. tuberculosis [25,57]. MLPA uses
allele-specific ligation and stuffer sequences of variable lengths,
which allow multiplexed typing with a capillary electrophoresis
device. The high level of multiplexing is made possible by the
PCR-amplification of the ligated oligonucleotides rather than the
amplification of template DNA. This allows the use of a universal
primer-pair for the singleplex-amplification of all ligated oligonu-
cleotides and avoids multiplex-PCR. Allele-specific ligation was
recently combined with the Luminex platform and named MOL-
PCR, and used for pathogen detection and SNP-typing of Bacillus
anthracis, Yersinia pestis, and Francisella tularensis [39,58]. MOL-PCR
uses fluorescent beads and coupled tag-sequences instead of stuffer
sequences for the multiplexed analysis. This allows the signal
detection on a flow cytometer, i.e. a Luminex device. We adapted
and modified MOL-PCR for typing of an 8-plex set of MTBC
lineage-specific SNPs. In our assay, the tag-sequences complemen-
tary to antiTag-sequences on microspheres were included on the
left-probe-oligonucleotide (LPO), i.e. preceding the 59-end of the
allele-discriminating sequence (left-hybridizing sequence, LHS),
contrary to the original publication of MOL-PCR [39], where tag-
sequences were included on the right-probe-oligonucleotide
(RPO). With this modification in oligonucleotide design, two
competing LPO could be used, differing only by the 39-end (the
SNP of interest) and the tag-sequence. This change allowed the
calculation of an allelic ratio rather than a signal-to-noise ratio,
and improved the sensitivity by discriminating background signal
from uncalled allele signal. An additional change was made in
separating the hybridization/ligation step from the PCR step. We
obtained high background signal levels when combining these two
steps. The assay therefore consisted of three steps (Figure 2): 1.
Competitive hybridization of allele-specific probes and ligation to
universal, 39-adjacent probes. This step provides the allele-
specificity of the assay. 2. Signal amplification by PCR and a
fluorescently labeled primer, which guarantees the sensitivity. 3.
Detection of allele-specific signals by hybridizing amplicons to
allele-specific beads and read-out by flow cytometry.
SNP selection and MOL-PCR oligonucleotide design
The selection of suitable SNPs is crucial for the success of a
typing assay. In MOL-PCR, probes of 20–45 bp are designed to
anneal directly adjacent to the SNP of interest. The need for a
suitable sequence up- and downstream of the SNP requires a
number of SNPs to choose from as a starting point. Eligible SNPs
for MOL-PCR were chosen using following criteria:
1. SNP is specific for the lineage of interest
2. SNP is not in a region where a genomic deletion has been
described (to ensure binding of oligonucleotides and subse-
quent allele-calls for all strains)
Figure 1. Phylogenetic tree of 22 whole genome sequences of MTBC plus Mycobacterium canettii as outgroup, and canonical SNPs
used for MOL-PCR and TaqMan assays. Rv-numbers in grey arrows represent SNPs used for MOL-PCR and TaqMan in this study, respectively,
and nucleotide change at the position in the annotated reference sequence of H37Rv [56]. The first number indicates the SNP used for MOL-PCR, and
the italic number the SNP used for TaqMan. Assays for the ‘‘Beijing’’ sublineage of Lineage 2 and for M. bovis/M. caprae were developed only for MOL-
PCR (modified from [51]).
doi:10.1371/journal.pone.0041253.g001
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3. No other SNP less than 50 bp up- or downstream (to avoid
mismatches in oligonucleotide annealing)
4. SNP is not a transition (i.e. no nucleotide change A.G, G.A,
C.T or T.C; lower unspecific signal because no alternate
base pairing possible)
5. SNP is in a coding sequence (deletions or insertions less likely)
6. SNP is in an essential gene (deletions less likely)
7. SNP change is synonymous (no amino acid change; therefore
lower selective pressure acting on SNP compared to non-
synonymous SNP)
For each eligible SNP, 100 bp of enclosing genomic sequence of
H37Rv up- and downstream of the SNP were obtained using
Ugene [59] and saved as multifasta file. Sequences and SNPs were
introduced in AlleleID (Premier Biosoft, Palo Alto, USA) and
suitable oligonucleotides searched using the MLPA module. As
MLPA uses stuffer sequences rather than tag-sequences (for
hybridizing to microspheres with coupled antitag-oligonucleotides),
the latter were introduced manually and according to sequences
provided by Luminex Corporation (Austin, USA). We used the
following criteria for oligonucleotide search in AlleleID: 1. GC-
content between 35% and 65%, 2. Tm between 72uC and 90uC,
3. Minimum left and right hybridization sequence (LHS and RHS)
length 21 bp. Probes with high scores in AlleleID were exported
from AlleleID to OpenOffice spreadsheets. BLAST search against
M. tuberculosis H37Rv was run to exclude cross-homology. The 24
oligonucleotides for each lineage-specific SNP were pooled (3
oligonucleotides each) and assessed for heterodimer formation
with SBEprimer [60], AutoDimer [61] and Oligoanalizer (www.
idtdna.com). Probes with potential dimer formation
(dG,211 kcal/mol) were excluded, a new SNP chosen and
new probes designed, until a compatible set was found. The final
set of 24 oligonucleotides was synthesized by Sigma-Aldrich
(Buchs, Switzerland). The 59-end of each RPO was phosphory-
lated to enable ligation.
Luminex MOL-PCR procedure
All SNPs were interrogated in one tube (multiplexed). Our
modified MOL-PCR assay consisted of three laboratory steps. 1.
Oligonucleotides were hybridized to target DNA and ligated. 2.
The ligation product was amplified by singleplex PCR (one primer
pair for all SNPs). 3. Beads were hybridized to the amplification
products and run on a flow cytometric device.
Hybridization and ligation. In a 10 mL volume with H2O,
0.5 mL of oligonucleotide-mix (40 nM each oligonucleotide; see
Table 1) were mixed with 1 mL of ligation buffer (NEB; New
England Biolabs, Ipswich, USA), 0.1 mL of thermostable ligase
(NEB) and 3 mL of pure DNA (10 ng/mL) or 4 mL heat-
inactivated, crude extract. In a thermocycler, the following
Figure 2. Schematic illustration of MOL-PCR. A. Three oligonucleotides and two fluorescently labelled beads are used for interrogation of one
SNP. B. MOL-PCR consists of three steps. 1. One of two competitive allele-specific left-hand probe oligonucleotides (LPO) and one universal right-
hand probe oligonucleotide (RPO) are hybridized to the template DNA and ligated. 2. With PCR and a reporter-labelled forward primer, the ligated
oligonucleotides (LPO+RPO) are amplified. 3. After denaturation of the PCR product, allele-specific fluorescent beads carrying an allele-specific
antiTag sequence are hybridized to the amplicons. This will result in beads carrying reporter fluorescence (bead 1 in example) and beads not carrying
fluorescence (bead 2). Reporter fluorescence (Alexa532) per bead is measured with a flow cytometric device (Luminex). For the 8-plex assay, a total of
24 oligonucleotides and 16 beads are used in the same reaction.
doi:10.1371/journal.pone.0041253.g002
SNP-Typing for M. tuberculosis Complex
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protocol was run: 4 min 94uC, 30 cycles 25 sec 94uC and 30 sec
50uC.
PCR: In a 10 mL volume, 3 mL of the ligation product was
added to the PCR mix of 5.095 mL of H2O, 1 mL PCR buffer
without MgCl2 (Roche, Basel, Switzerland), 0.2 mL dNTPs
(10 mM, Sigma-Aldrich), 0.5 mL forward primer (10 mM; Sigma-
Aldrich, 59-Alexa532-GGGTTCCCTAAGGGTTGGA),
0.125 mL reverse primer (10 mM; Sigma-Aldrich, GTGCCAG-
CAAGATCCAATCTAGA) and 0.08 mL FastStart Taq polymer-
ase (Roche). The following protocol was run in a thermocycler:
2 min 96uC and 43 cycles of 20 sec 94uC, 20 sec 58uC, 20 sec
72uC.
Hybridization of beads and signal detection. A bead mix
containing 2 mL of beads (16 polystyrene bead regions of
MagPlex-Tag beads, Luminex Corp., Austin, USA; Table 1)
and 3 mL of buffer (1.33 M NaCl (Merck Chemicals, Darmstadt,
Germany), 83.33 mM MES (Sigma-Aldrich)) was added to the
10 mL PCR product. In a thermocycler, the following protocol was
run to hybridize beads (antiTags) to PCR products (tags): 1 min
94uC, ramp-down 0.1uC/sec decrement to 25uC, 5 min 25uC.
80 mL of running buffer (10 mM Tris-HCl, 0.1 mM EDTA
(Sigma-Aldrich), 90 mM NaCl, 0.04% (v/v) Triton X-100 (Sigma-
Aldrich), pH 8) were added and the reaction transferred to flat-
bottom plates (BioRad, Hercules, USA). A BioPlex 200 device
(BioRad) was used to discriminate beads and measure reporter
fluorescence (Alexa532) for each bead, i.e. each allele. Results
were obtained as reporter median fluorescence intensity (MFI) per
bead region and sample, and exported from BioPlex Manager
software into spreadsheets.
Allele calling MOL-PCR
For each sample, the allelic state of each SNP was assessed with
the following algorithm:
1. Bead counts .40 beads per bead region
2. Allelic ratio (AR),0.4; ancestral allele called
3. Allelic ratio (AR).0.6; mutant allele called
AR = (MFImutant/MFIH2O_mutant)/((MFImutant/MFIH2O_mutant)
+(MFIancestral/MFIH2O_ancestral))
1. MFI.threshold MFI (see below)
MFI = median fluorescence intensity of reporter-dye (Alexa532)
of the corresponding allele/bead region
A threshold MFI for each allele/bead was used to exclude low
signal calls and to avoid SNP-calls for H2O signals (false-positives).
This value was different for each SNP and each allele (i.e. each
bead region) and had to be calculated for each run, as we observed
significant differences of H2O signal levels between different runs,
and occasionally H2O signal levels higher than uncalled allele
signals. The pragmatic approach that we used to calculate the
signal threshold for allele was the following. For each allele, the
threshold was set higher than each of the corresponding H2O
values (a minimum of three H2O samples per 96-well-plate were
included). The threshold was then lowered so far that no allele was
called for any of the H2O-sample, which is made possible by the
range of the allelic ratio. Furthermore, an absolute minimal
threshold value was used.
Assay description TaqMan PCR
TaqMan real-time PCR was originally described in 1991 [62]
and was since then optimized for commercial use. The PCR based
method makes use of fluorescently labeled allele-specific probes,
the 59-39-exonuclease activity of Taq polymerase and a non-
fluorescent quencher. During PCR amplification of the region of
interest, fluorescence is detected in a real-time PCR thermocycler.
SNP selection and probe design for TaqMan
Primers and probes for Lineage 2, Lineage 3 and Lineage 4
were described before (Table 2). SNP for Lineage 1 was chosen
from the list of lineage-specific SNPs recently published [10], and
SNPs for Lineage 5 and 6 from the list of genome sequences as
described above. For the design of probes and primers, the
software Primer Express (Applied Biosystems, Carlsbad, USA) was
used. As TaqMan assays were singleplex, oligonucleotide design
was less complex, as heterodimer formation is limited to the two
primers and two probes of one assay. Furthermore, the design of
the primer pair can be varied over a large sequence range.
TaqMan real-time PCR
TaqMan real-time PCR was performed according to standard
protocols (Applied Biosystems, Carlsbad, USA). Briefly, in a 12 mL
volume, 2 mL DNA sample were added to a mix of 5 mL TaqMan
Universal MasterMix II (Applied Biosystems), 5 mL H2O contain-
ing forward and reverse primer (0.21 mM each; Sigma-Aldrich),
probe A for ancestral allele and probe B for mutant allele
(0.83 mM each; Applied Biosystems). Primer and probe sequences
are listed in Table 2. Reactions were run in a StepOnePlus
thermocycler (Applied Biosystems; 60uC 30 sec; 95uC 10 min;
95uC 15 sec and 60uC 1 min for 40 cycles; 60uC 30 sec) and
fluorescence intensity in the VIC and FAM channels measured at
the end of every cycle. Results were analyzed with StepOne
software (Applied Biosystems) and alleles called with the default
algorithm.
Spoligotyping
43-spacer spoligotyping was performed following standard
protocols on a membrane [12].
PCR and sequencing of putative deletion in Rv3113
As we did not obtain MOL-PCR signal for the M. bovis/M.
caprae-specific SNP for two strains (N1007 and N1032, see Table
S1), the locus was assessed for a potential deletion in Rv3113. PCR
was run in a 25 mL volume with 12.3 mL H2O, 2.5 mL PCR buffer
with MgCl2 (Roche), 5 mL GC buffer, 0.75 mL forward primer K-
297 (10 mM, Sigma-Aldrich, CCATGATGCTGGCA-
GAACTGA), 0.75 mL reverse primer K-298 (10 mM, Sigma-
Aldrich, CCTGCGTACCTTCGTCGTCA), 0.5 mL dNTPs
(10 mM, Qiagen, Hombrechtikon, Switzerland) and 0.2 mL Fast
Start Taq Polymerase (Roche). Reaction was run in a standard
thermocycler (96uC, 7 min; 35 cycles of 96uC 30 sec, 62uC 30 sec,
72uC 30 sec; 72uC 4 min). PCR product was analyzed using
standard gel electrophoresis and stained with ethidium bromide.
Results
Eight SNPs were used in the multiplexed MOL-PCR assay
(Table 1). Six SNPs were interrogated serially with TaqMan assays
(Table 2). Forty-six MTBC strains were run as a ‘‘training panel’’
(Table S1). Most samples were available as 10 ng/mL purified
genomic DNA (CTAB-method) and as crude lysates from 7H9
culture. Both methods, MOL-PCR and TaqMan, were run in
parallel for all samples and all SNPs. Table S1 shows allelic state
for each SNP for both purified DNAs and crude extracts, called by
MOL-PCR and TaqMan, respectively.
For MOL-PCR, 662 of 672 (98.6%) total data points (alleles)
resulted in a successful call of either the ancestral or the mutant
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allele (Table S1 and Table 3). Eight data points, for which no allele
call was obtained, involved crude lysates, and two were purified
DNA samples. For two strains, N1007 and N1032, no allele was
called for the M. bovis/M. caprae-specific SNP, Rv3480645TG, for
both crude and purified DNA. To test for a potential deletion in
the corresponding genomic region, we designed PCR primers and
amplified the region up- and downstream of this SNP. Gel
electrophoresis showed an expected amplicon length of approx-
imately 250 bp for H37Rv, but no band for the two strains in
question, suggesting that this region was deleted in strains N1007
and N1032 (Figure S1).
For TaqMan PCR, 498 alleles of 504 (98.8%) total data points
were successfully called (Table S1 and Table 3). The remaining six
data points without allele calls were two crude lysates and four
purified DNA samples. There was no case where TaqMan PCR
failed to call an allele for both purified and heat-inactivated
sample.
Both methods agreed 100% in lineage assignment of the 36
strains comprising the training panel (excluding M. bovis, M. caprae,
M. microti and M. pinnipedi, as no SNP for M. bovis/M. caprae was
used in the TaqMan assay) (Table 4). Using the prototype spacer
definitions [63,64], spoligotyping data confirmed the lineage-
assignments of TaqMan and MOL-PCR for 39 of 42 strains
(excluding M. microti/M. pinnipedii). Of the three remaining strains,
N0153 and N0051 could not be classified into any of the known
spoligotype families. Strain N1024 showed a ‘‘Beijing’’ spoligo-
pattern and was confirmed by TaqMan and MOL-PCR as a
Lineage 3 (also known as CAS/Dehli) strain (Table 3). The
spoligotype of this strain was described as ‘‘Pseudo-Beijing’’
previously [14].
Next, we used a test panel of 78 clinical isolates from Nepal to
validate our methods (Table S2). These samples were mainly
crude, heat-inactivated extracts, and no genotyping had been done
before. To follow the procedure that would be used as routine
SNP-typing, we first performed MOL-PCR, as information for all
SNPs is obtained in parallel. Of a total of 624 data points (i.e. 78
strains and eight SNPs), 619 (99.2%) allele calls were obtained
(Table S2 and Table 3). The five data points with no calls were
from three strains (1671A, 3052B and 3074B). Thereof, two strains
(1671A, 3074B) failed to be assigned to a lineage by MOL-PCR
(97.4% sensitivity in lineage assignment). Nevertheless, we
obtained ancestral allele calls for seven (1671B) and six (3074B)
other SNPs for these strains. We then performed the correspond-
ing TaqMan assay for each sample. TaqMan called alleles for all
78 samples. Again, lineage-assignment was 100% congruent
between MOL-PCR and TaqMan.
To evaluate the signal detection limit of MOL-PCR, we used
different DNA concentrations as input material. Samples with
known DNA concentration were diluted appropriately for
different amounts of input DNA. One strain of each lineage was
used and MOL-PCR performed with 60 ng, 10 ng, 1 ng, 0.1 ng
purified DNA, and 4 mL of crude, heat-inactivated extract. Figures
S2, S3, S4, S5, S6, S7 and S8 show a decrease of signal intensities
with decreasing amount of DNA. Nevertheless, the use of 0.1 ng
purified DNA (CTAB) or 4 mL crude extract still resulted in signals
high enough for allelic ratio determination. Signal intensities of the
complementary allele were constantly low.
Discussion
Informative SNPs are valuable markers for deep phylogenetic
typing of clinical MTBC isolates [11]. Therefore, SNP-typing will
likely play an important role for genotype-phenotype association
studies in the coming years. Even though routine whole-genome-
sequencing, i.e. ‘‘genometyping’’, might replace most other typing
methods eventually, current limitations such as costs, bioinfor-
matics capacity, the lack of user-friendly software packages, and
data storage has been hindering the broad implementation of
‘‘genometyping’’ [1,11]. Nevertheless, thousands of informative
SNPs have become available from whole genome sequences,
which can be used for SNP-typing.
In this study, we presented 14 canonical SNPs, comprising two
sets of markers for the six main phylogenetic lineages of MTBC,
the M. bovis/M. caprae clade and the ‘‘Beijing’’ sublineage. In
contrast to other published SNP sets [23,24], our SNPs were
obtained from many whole genome sequences representing the
global diversity of MTBC, and thus do not suffer from
phylogenetic discovery bias [65]. Phylogenetic discovery bias
occurs when SNPs used for subsequent genotyping are initially
identified by comparing only a few whole genome sequences (for
example when these genomes represent only a subset of all MTBC
lineages). As a result, strains belonging to lineages not represented
in the initial genome set will falsely appear as intermediates in the
corresponding phylogenies [66]. In additional advantage of our
SNP sets is that they also identify Mycobacterium africanum [67] and
discriminate between the West-African I and the West-African II
subtypes (i.e. MTBC Lineages 5 and 6). Moreover, the addition of
a ‘‘Beijing’’-specific SNP makes the differentiation between this
sublineage and other strains of Lineage 2 (East-Asian) possible.
For the rapid typing of the SNPs described, we have successfully
developed a multiplexed assay adapted from MOL-PCR [39].
Our assay uses three oligonucleotides per SNP instead of two, with
the LPOs competing for annealing to the template DNA. This
allows an allele-call based on allelic ratio rather than signal-to-
noise ratio, which increases sensitivity. We further separated the
hybridization/ligation from the PCR step, which reduced
unspecific signal. We compared the new MOL-PCR assay with
TaqMan real-time PCR which was used as standard SNP-typing
method in our laboratory. We found an agreement of 100% in
classifying strains into the main phylogenetic lineages and an
allele-calling sensitivity of 98.6% and 98.8%, respectively, when
typing two panels of clinical MTBC strains.
MOL-PCR was sensitive enough to be used with low
concentrations of DNA as well as heat-inactivated samples (crude
Table 3. Comparison of MOL-PCR and TaqMan for allele
calling and lineage assignment.
MOL-PCR TaqMan
Training panel Total data points 672 (100%)1 504 (100%)1
Data points with allele call 662 (98.6%) 498 (98.8%)
Total number of strains 42 (100%)2 36 (100%)3
Strains assigned to a lineage 42 (100%) 36 (100%)
Congruence in lineage
assignment
100%
Test panel Total data points 624 (100%) 78 (100%)
Data points with allele call 619 (99.2%) 78 (100%)
Total number of strains 78 78
Strains assigned to a lineage 76 (97.4%) 78 (100%)
Congruence in lineage
assignment
100%
1excluding N/A as indicated in Table S1.
2excluding M. microti, M. pinnipedi.
3excluding M. bovis, M. caprae, M. microti, M. pinnipedii.
doi:10.1371/journal.pone.0041253.t003
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Table 4. Lineage assignments of MOL-PCR, TaqMan and spoligotyping for the 46 MTBC strains as in Table S1.
Lineage assignment
MTBC strain MOL-PCR TaqMan Spoligotyping1 Spoligotype SITVIT lineage2 SIT2
N1004 1 1 1 &&&&&&&&&&&&&&&&&&&&&&%&&&&&
%%%%&%&&%&&&&&&
EAI6-BGD1 292
N1006 1 1 1 &&&&&&&&&&&&&&&&&&&&&&&&&&&&
%%%%&%%%&&&%%%%
EAI5 ORPHAN
N0153 1 1 -3 &&&&&&&&&&&&&&&&&&%%%%%%%%%%
%%%%%%%%%%%%%&&
ZERO 405
N1011 1 1 1 &&&&&&&&&&&&&&&&&&&&&&&&&&&&
%%%%&%%%&&&%%%%
EAI5 ORPHAN
N1030 1 1 1 &&&&&&&&&&&&&&&&&&&&&&&&&&&&
%%%%&%&&&&&%%%%
EAI5 138
N1068 1 1 1 &%%&&&&&&&&&&%&&&&&&&&&&&&&&
%%%%&%&&%%%&&&&
EAI3-IND ORPHAN
N1053 2/Beijing 2 2 %%%%%%%%%%%%%%%%%%%%%%%%%%%%
%%%%%%&&&&&&&&&
BEIJING 1
N1002 2/Beijing 2 2 %%%%%%%%%%%%%%%%%%%%%%%%%%%%%
%%%%%&&&&&&&&&
BEIJING 1
N1010 2/Beijing 2 2 %%%%%%%%%%%%%%%%%%%%%%%%%%%%%
%%%%%&&&&&&&&&
BEIJING 1
N1012 2/Beijing 2 2 %%%%%%%%%%%%%%%%%%%%%%%%%%%%
%%%%%%&&&&&&&&&
BEIJING 1
N0051 2/non-Beijing 2 -3 %%%%%%%%%%%%%%%%%%%%%%%%&
&&&&&&&&&&&&&&&&&&
- 955
N1069 2/Beijing 2 2 %%%%%%%%%%%%%%%%%%%%%%%%
%%%%%%%%%%&&&&&&&&&
BEIJING 1
N1013 2/Beijing 2 2 %%%%%%%%%%%%%%%%%%%%%%%%%%
%%%%%%%%&&&&&&&&&
BEIJING 1
N1144 3 3 3 &&&%%%%&&&&&&&&&&&&&&&%%%%%%
%%%%%%&&&&&&&&&
CAS1-DELHI 26
N1007 3 3 3 &&&%%%%&&&&&&&&&&&&&&%%%%%%%
%%%%%%&&&&&&&&&
CAS 142
N1082 3 3 3 &&&%%%%&&&&&&&&&%&&&&&%%%%
%%%%%%%%&&&%%%%%&
- -
N1024 3 3 -4 %%%%%%%%%%%%%%%%%%%%%%%%%%
%%%%%%%%&&&&&&&&&
BEIJING 1
N1032 3 3 3 &&&%%%%&&&&&&&&&&&&&&&%%%%
%%%%%%%%&&&&&&&&&
CAS1-DELHI 26
N1021 3 3 3 &&&%%%%&&&&&&&&&&&&&&&%%%%
%%%%%%%%%%&&&&&&&
CAS 357
N1022 3 3 3 &&%%%%%&&&&&&&&&&&&&&&%%%%
%%%%%%%%&&%%&&&&&
- 2485
H37Rv 4 4 4 &&&&&&&&&&&&&&&&&&&%%&&&&&
&&&&&&%%%%&&&&&&&
H37RV 451
N1008 4 4 4 &%%&&&&&&&&&&&&&&&&&&&&&&&
&&&&%&%%%%&&&&&&&
H3 655
N1015 4 4 4 &&&&&&&&&&&&%%%%&&&&&&&&&&
&&&&&&%%%%&&&&&&&
T1 102
N1019 4 4 4 &&&%&&&&%%&&%&&&&&&&&&&&&&&
&&&&&%%%%&&&&%&&
- -
N1052 4 4 4 &&&&&&&&&&&&&&&&&&&&&&&&&&&
&&&&&%%%%&&&&&&&
T1 53
N1057 4 4 4 &&&&&&&&&&&&&&&&&&&&&&&&&&&
&&&&&%%%%&&%%%%&
T1 244
N1034 5 5 5 &&&&&&&%%%%%&&&&&&&&&&&&%&
%%%%%%%%%&%%%&&&&
- -
N1035 5 5 5 &&&&&&&%%%%%&&&&&&&&&&&&%
&%%%%%%%%%&%%%%&&&
- ORPHAN
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extracts) (Figures S2, S3, S4, S5, S6, S7 and S8). We found that the
detection limit of MOL-PCR was as low as 0.1 ng of input DNA.
Heat-inactivated samples resulted in similarly high signal levels.
This is especially valuable as performing MTBC cultures and
DNA extraction is laborious and time-consuming. Even though
the signal levels of H2O control reactions were at time relatively
high (Figures S2, S3, S4, S5, S6, S7 and S8), the MFI threshold
determination we applied allowed us to control for this, and water
samples could not be called false-positive alleles. We recommend
to include at least three water samples per 96-well plate, and to use
a mean value for the calculation of allelic ratios. Additionally, we
always included H2O control samples for the PCR step to detect
potential contamination.
We observed a putative deletion in the region of SNP
Rv3480645TG, as we did not obtain signal for neither allele for
two samples (N1007 and N1032). To our knowledge, no genomic
deletion has been described to span this SNP [19]. PCR
amplification of this region resulted in no visible band for these
two samples (Figure S1), which suggested that there might be a
deletion present in some Lineage 3 (CAS/Delhi) strains. This
highlights the fact that genomic deletions can affect a SNP call,
even though the corresponding gene was originally described as
essential [54,55]. However, with MOL-PCR we always generated
complete allelic information for all other SNPs of the assay. As the
canonical SNPs defining different MTBC lineages are mutually
exclusive (except Lineage 2 and Beijing), the lack of an allelic call
for one SNP can be neglected if the alleles at other loci are called
successfully.
A limitation in the development of the MOL-PCR assay was the
low efficiency of design and validation of oligonucleotides. For
Table 4. Cont.
Lineage assignment
MTBC strain MOL-PCR TaqMan Spoligotyping1 Spoligotype SITVIT lineage2 SIT2
N1063 5 5 5 &&&&&&&%%%%%%&&&&&&&%%%%
&&&&&&&%%%%%%%%&&&&
- -
N1064 5 5 5 &&&&&&&%%%%%&&&&&&&&%%%%&
&%&&&&&%&&&%%%&&&&
AFRI_2 101
N1286 5 5 5 &&&&&&&%%%%%&&&&&&&%%%%%%
%%&&%%%%%&&%%%%&&&
- -
N1201 6 6 6 &&&&&&%%%&&&&&&&&&&&&%%%&
&&&&&&&&&&&&&%%&&&
- 3476
N1292 6 6 6 &&&&&&%%%&%%&&&&&&&&&%%%&&&
&&&&&&&&&&&%&&&&
- -
N0091 6 6 6 &&&&&&%%%&&&&&&&&&&&&&&&&&&
&&&&&&&&&&&%&&&&
AFRI_1 181
N0092 6 6 6 &&&&&&%%%&&&&&&&&&&&&&&&&&&
&&&&&&&&&&&%&&&&
AFRI_1 181
N0115 6 6 6 &&&&&&%%%&&&&&&&&&&&&&&&&&&
&&&&&&&&&&&%&&&&
AFRI_1 181
M. bovis
BCG Pasteur
M. bovis/M.
caprae
(N/A) M. bovis &&%&&&&&%&&&&&&%&&&&&&&&&&
&&&&&&&&&&&&%%%%%
BOV_1 482
M. bovis
BCG
Montreal
M. bovis/M.
caprae
(N/A) M. bovis &&%&&&&&%&&&&&&%&&&&&&&&&
&&&&&&&&&&&&&%%%%%
BOV_1 482
M. bovis
1290-03
M. bovis/M.
caprae
(N/A) M. bovis &&%%%&&&%&&&&&&%&&&&&&&&&&&
&&&&&&&&&&&%%%%%
BOV_1 665
M. bovis
8217-02
M. bovis/M.
caprae
(N/A) M. bovis &&%&&&&&%&&&&&&%&&&&&&&&&&
&&&%&&&&&&&&%%%%%
BOV_1 1037
M. caprae
7140-99
M. bovis/M.
caprae
(N/A) (N/A) %&%%%%%%%%%%%%%%&&&&&&&&&&&
%&&&&&&&&&&%%%%%
BOV4_CAPRAE 647
M. caprae
8986-99
M. bovis/M.
caprae
(N/A) (N/A) %&%%%%%%%%%%%%%%&&&&&&&&%%
%%%%%%%%%%%%%%%%%
BOV4_CAPRAE 818
M. microti
1479-00
- (N/A) (N/A) %%%%%%%%%%%%%%%%%%%%%%%%%%
%%%%%%%%%%&&%%%%%
MICROTI 539
M. microti
8753-00
- (N/A) (N/A) %%%&&&&%%%%%%%%%%%%%%%&&%
&%%%%%%%%%%&&%%%%%
PINI1 642
M.
pinnipedii
7011-02
- (N/A) (N/A) %%%&&&&%%%%%%%%%%%%%%%&&&
&%%&&&&&&&&&&%%%%%
- -
M. pinnipedii
7739-01
- (N/A) (N/A) %%%&&&&%%%%%%%%%%%%%%%&&&&%
%&&&&&&&&&&%%%%%
- -
1Lineage-classification using spoligotype prototypes as described in [10,63,64].
2As described in [64].
3No lineage-classification possible based on spoligotyping.
4‘‘Pseudo-Beijing’’ as described in [14].
doi:10.1371/journal.pone.0041253.t004
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each lineage, we had to design up to 5 sets of probes targeting
different SNPs, because many had to be rejected during validation,
most often because of unfavorable allelic or signal-to-noise ratios
or lack of signal. The use of long (i.e. 40–140 bp) oligonucleotides
makes hairpin and homodimer formations likely, and multiplexing
probes adds a level of complexity due to a high combinatorial
number of possible heterodimer formations. We used different
software for homo- and heterodimer analysis, but still were not
able to fully predict the success of probes. Recently, an online tool
for MOL-PCR specific oligonucleotide design and evaluation
became available (moligodesigner.lanl.gov) [58], which could
strongly facilitate the design of such oligonucleotides. Further-
more, an oligonucleotide design tool for copy-number-variation
analysis of human, mouse and rat genomes with MLPA and
MOL-PCR has been described [68,69], and might be extended to
SNP analysis and bacterial genomes.
Four other methods have been described for multiplexed SNP-
typing on the Luminex platform, namely Direct Hybridization,
Allele-Specific Primer Extension, Single-Base-Extension and
Oligonucleotide Ligation [40,41]. In contrast to MOL-PCR,
these methods use multiplex-PCR for amplification of template
DNA. This makes high multiplex-levels difficult, as a multiplex
PCR is usually the limiting factor in multiplexed assays. In our
assay, 24 oligonucleotides of 48 to 80 bp lengths were included for
eight SNPs. A number of additional SNPs could be interrogated in
the same reaction, i.e. for sublineages, drug resistance mutations
[25] or outbreak-specific SNPs [70].
In addition to MOL-PCR, we also developed TaqMan SNP-
assays for robust and rapid singleplex-typing of all main MTBC
lineages. TaqMan SNP-typing is a well-established method for
genotyping and available commercially. This facilitates the design
and validation of probes, and provides standardized reaction
conditions. Furthermore, criteria of TaqMan primer and probe
design are less strict than in MOL-PCR. TaqMan makes use of
quantitative PCR, which renders the method particularly sensitive.
On the other hand, multiplexing of TaqMan assays is demanding
and the degree of multiplexing is limited. Hence, we recommend
using MOL-PCR for strain collections with no a priori information.
TaqMan SNP-typing, on the other hand, is most suitable for
confirmation of MOL-PCR results, or for strain collections for
which previous information about genotypes is available.
Costs for reagents and consumables are another important
consideration when implementing a new technique. Similar to
other methods, running costs of MOL-PCR per SNP decrease
with increasing number of multiplexed SNPs. We have estimated
the minimal reagent costs per SNP to be ,0.8 Euro when run in a
singleplex reaction. Reagent costs drop to ,0.15 Euro per SNP
when running an 8-plex reaction. The cost of one TaqMan
reaction was estimated at,0.9 Euro per SNP. For both assays, the
initial setup costs are relatively high due to purchase of customized
and labeled oligonucleotides. Furthermore, both methods require
an expensive piece of equipment in form of a Luminex or a real-
time-PCR machine. However, both of these devices can be used
for a wide variety of applications in addition to SNP-typing (e.g.
spoligotyping on the Luminex platform [71]), and many labora-
tories already have access to such equipment.
In conclusion, we propose a new set of canonical SNPs specific
for the main phylogenetic lineages of MTBC. When combined
with multiplexed MOL-PCR or singleplex TaqMan SNP-typing,
these SNPs are ideal for phylotyping of strain collections from a
small to a large scale. These assays provide a new basis for
phylogenetically robust classification of clinical isolates.
Supporting Information
Figure S1 Agarose gel of PCR product of Rv3114
covering the SNP specific for M. bovis/M. caprae
(Rv3480645TG). H37Rv was used as positive control, whereas
N1007 and N1032 were the samples that did not result in any
signal in MOL-PCR. Ladder is Hyperladder II (Bioline).
(PDF)
Figure S2 Dilution series of DNA from a clinical isolate
of Lineage 1. Strain N1004 was previously characterized as
strain of Lineage 1. Median reporter fluorescence intensities
(Alexa532-primer) of MOL-PCR are shown for each bead region
and by different DNA amounts (CTAB-extracted) or crude extract
(heat-inactivated). Error bars represent standard deviations
calculated from triplicates.
(PDF)
Figure S3 Dilution series of DNA from a clinical isolate
of Lineage 2/Beijing. Strain N1053 was previously character-
ized as strain of Lineage 2/Beijing. Median reporter fluorescence
intensities (Alexa532-primer) of MOL-PCR are shown for each
bead region and by different DNA amounts (CTAB-extracted) or
crude extract (heat-inactivated). Error bars represent standard
deviations calculated from triplicates.
(PDF)
Figure S4 Dilution series of DNA from a clinical isolate
of Lineage 3. Strain N1144 was previously characterized as
strain of Lineage 3. Median reporter fluorescence intensities
(Alexa532-primer) of MOL-PCR are shown for each bead region
and by different DNA amounts (CTAB-extracted) or crude extract
(heat-inactivated). Error bars represent standard deviations
calculated from triplicates.
(PDF)
Figure S5 Dilution series of DNA from a clinical isolate
of Lineage 4. Strain N1015 was previously characterized as
strain of Lineage 4. Median reporter fluorescence intensities
(Alexa532-primer) of MOL-PCR are shown for each bead region
and by different DNA amounts (CTAB-extracted) or crude extract
(heat-inactivated). Error bars represent standard deviations
calculated from triplicates.
(PDF)
Figure S6 Dilution series of DNA from a clinical isolate
of Lineage 5. Strain N1286 was previously characterized as
strain of Lineage 5. Median reporter fluorescence intensities
(Alexa532-primer) of MOL-PCR are shown for each bead region
and by different DNA amounts (CTAB-extracted) or crude extract
(heat-inactivated). Error bars represent standard deviations
calculated from triplicates.
(PDF)
Figure S7 Dilution series of DNA from a clinical isolate
of Lineage 6. Strain N1200 was previously characterized as
strain of Lineage 6. Median reporter fluorescence intensities
(Alexa532-primer) of MOL-PCR are shown for each bead region
and by different DNA amounts (CTAB-extracted) or crude extract
(heat-inactivated). Error bars represent standard deviations
calculated from triplicates.
(PDF)
Figure S8 Dilution series of DNA from M. bovis BCG
Pasteur. Median reporter fluorescence intensities (Alexa532-
primer) of MOL-PCR are shown for each bead region and by
different DNA amounts (CTAB-extracted) or crude extract (heat-
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inactivated). Error bars represent standard deviations calculated
from triplicates.
(PDF)
Table S1 MOL-PCR and TaqMan allele calls for the
training panel of 46 well-characterized MTBC strains.
(XLS)
Table S2 MOL-PCR and TaqMan allele calls for the test
panel of 78 MTBC strains with no previous genotyping
information.
(XLS)
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